☰

Dmitry I. Gabrilovich - Publications

Affiliations: 
Biology (Cell Biology, Microbiology, Molecular Biology) University of South Florida, Tampa, FL, United States 
Area:
Immunology, Oncology
Tree Info Grants Similar researchers PubMed Report error

287 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Hardaker EL, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C, Hughes A, Mai M, King M, Solanki A, Magiera L, Miragaia R, Kar G, Standifer N, Surace M, ... ... Gabrilovich DI, et al. The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment. Nature Communications. 15: 1700. PMID 38402224 DOI: 10.1038/s41467-024-45996-4  0.47
2023 von Wulffen M, Luehrmann V, Robeck S, Russo A, Fischer-Riepe L, van den Bosch M, van Lent P, Loser K, Gabrilovich DI, Hermann S, Roth J, Vogl T. S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Reports. 42: 113006. PMID 37610870 DOI: 10.1016/j.celrep.2023.113006  0.366
2023 Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends in Pharmacological Sciences. PMID 37380530 DOI: 10.1016/j.tips.2023.06.005  0.481
2023 Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, Guo X, Nivelo LA, Kolonias DS, Saigh SJ, Wieder E, Rafie CI, Dosch AR, Zhou Z, Umland O, ... ... Gabrilovich DI, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discovery. PMID 36946782 DOI: 10.1158/2159-8290.CD-22-1046  0.473
2023 Lin C, Garcia-Gerique L, Bonner EE, Mastio J, Rosenwasser M, Cruz Z, Lawler M, Bernabei L, Muthumani K, Liu Q, Poncz M, Vogl T, Törngren M, Eriksson H, Vogl DT, ... Gabrilovich DI, et al. S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes. Cancer Research Communications. 3: 420-430. PMID 36923707 DOI: 10.1158/2767-9764.CRC-22-0368  0.394
2023 van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI. Functional states of myeloid cells in cancer. Cancer Cell. PMID 36868224 DOI: 10.1016/j.ccell.2023.02.009  0.399
2023 Barry ST, Gabrilovich DI, Sansom OJ, Campbell AD, Morton JP. Therapeutic targeting of tumour myeloid cells. Nature Reviews. Cancer. PMID 36747021 DOI: 10.1038/s41568-022-00546-2  0.35
2022 Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, Mostafa A, Alicea-Torres K, Garcia-Gerique L, Stone EL, Kossenkov AV, Schug ZT, Nam B, Mulligan C, Altieri DC, ... ... Gabrilovich DI, et al. Syntaphilin regulates neutrophil migration in cancer. Cancer Immunology Research. PMID 36548516 DOI: 10.1158/2326-6066.CIR-22-0035  0.441
2022 Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, Fu S, Sehgal M, Garcia-Gerique L, Kossenkov A, Gebregziabher BA, Tobias JW, Hicks K, Halpin RA, Cvetesic N, ... ... Gabrilovich DI, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. PMID 36385526 DOI: 10.1038/s41586-022-05443-0  0.372
2022 Zhang H, Tomar VS, Li J, Basavaraja R, Yan F, Gui J, McBrearty N, Costich TL, Beiting DP, Blanco MA, Nefedova Y, Conejo-Garcia JR, Saggu G, Berger AJ, Gabrilovich DI, et al. Protection of regulatory T cells from fragility and inactivation in the tumor microenvironment. Cancer Immunology Research. PMID 36255418 DOI: 10.1158/2326-6066.CIR-22-0295  0.492
2022 Tcyganov EN, Sanseviero E, Marvel D, Beer T, Tang HY, Hembach P, Speicher DW, Zhang Q, Donthireddy LR, Mostafa A, Tsyganova S, Pisarev V, Laufer T, Ignatov D, Ferrone S, ... ... Gabrilovich DI, et al. Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy. Cancer Cell. 40: 1173-1189.e6. PMID 36220073 DOI: 10.1016/j.ccell.2022.09.001  0.4
2022 Deng H, Lin C, Garcia-Gerique L, Fu S, Cruz Z, Bonner EE, Rosenwasser M, Rajagopal S, Sadhu MN, Gajendran C, Zainuddin M, Gosu R, Sivanandhan D, Shelef MA, Nam B, ... ... Gabrilovich DI, et al. A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression. Cancer Research. PMID 36069973 DOI: 10.1158/0008-5472.CAN-21-4045  0.364
2022 Jiménez-Cortegana C, Galassi C, Klapp V, Gabrilovich DI, Galluzzi L. Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research. 10: 545-557. PMID 35426936 DOI: 10.1158/2326-6066.CIR-21-1105  0.411
2022 Donthireddy L, Vonteddu P, Murthy T, Kwak T, Eraslan RN, Podojil JR, Elhofy A, Boyne MT, Puisis JJ, Veglia F, Singh SS, Dotiwala F, Montaner LJ, Gabrilovich DI. ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts. Journal of Cancer. 13: 1933-1944. PMID 35399717 DOI: 10.7150/jca.69338  0.392
2021 Hicks KC, Tyurina YY, Kagan VE, Gabrilovich DI. Myeloid Cell-Derived Oxidized Lipids and Regulation of the Tumor Microenvironment. Cancer Research. PMID 34764204 DOI: 10.1158/0008-5472.CAN-21-3054  0.416
2021 Grover A, Sanseviero E, Timosenko E, Gabrilovich DI. Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic. Cancer Discovery. 11: 2693-2706. PMID 34635571 DOI: 10.1158/2159-8290.CD-21-0764  0.369
2021 Hashimoto A, Sarker D, Reebye V, Jarvis S, Sodergren MH, Kossenkov A, Sanseviero E, Raulf N, Vasara J, Andrikakou P, Meyer T, Huang KW, Plummer R, Chee CE, Spalding D, ... ... Gabrilovich DI, et al. Up-regulation of C/EBPα inhibits suppressive activity of myeloid cells and potentiates antitumor response in mice and cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34407972 DOI: 10.1158/1078-0432.CCR-21-0986  0.334
2021 Gabrilovich DI. The Dawn of Myeloid-Derived Suppressor Cells: Identification of Arginase I as the Mechanism of Immune Suppression. Cancer Research. 81: 3953-3955. PMID 34341063 DOI: 10.1158/0008-5472.CAN-21-1237  0.485
2021 Tcyganov EN, Hanabuchi S, Hashimoto A, Campbell D, Kar G, Slidel TW, Cayatte C, Landry A, Pilataxi F, Hayes S, Dougherty B, Hicks KC, Mulgrew K, Tang CA, Hu CA, ... ... Gabrilovich DI, et al. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer. The Journal of Clinical Investigation. PMID 34228641 DOI: 10.1172/JCI145971  0.4
2021 Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, Donthireddy L, Kossenkov A, Lin C, Fu S, Mulligan C, Nam B, Masters G, Denstman F, Bennett J, ... ... Gabrilovich DI, et al. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. Nature Communications. 12: 1717. PMID 33741967 DOI: 10.1038/s41467-021-22033-2  0.46
2021 Veglia F, Hashimoto A, Dweep H, Sanseviero E, De Leo A, Tcyganov E, Kossenkov A, Mulligan C, Nam B, Masters G, Patel J, Bhargava V, Wilkinson P, Smirnov D, Sepulveda MA, ... ... Gabrilovich DI, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. The Journal of Experimental Medicine. 218. PMID 33566112 DOI: 10.1084/jem.20201803  0.444
2021 Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nature Reviews. Immunology. PMID 33526920 DOI: 10.1038/s41577-020-00490-y  0.392
2021 Hao X, Zhao B, Zhou W, Liu H, Fukumoto T, Gabrilovich D, Zhang R. Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype. Iscience. 24: 102016. PMID 33490922 DOI: 10.1016/j.isci.2020.102016  0.447
2021 Somasundaram R, Connelly T, Choi R, Choi H, Samarkina A, Li L, Gregorio E, Chen Y, Thakur R, Abdel-Mohsen M, Beqiri M, Kiernan M, Perego M, Wang F, Xiao M, ... ... Gabrilovich D, et al. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nature Communications. 12: 346. PMID 33436641 DOI: 10.1038/s41467-020-20600-7  0.352
2021 Sanseviero E, Kim R, Gabrilovich DI. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models. Methods in Molecular Biology (Clifton, N.J.). 2236: 19-28. PMID 33237537 DOI: 10.1007/978-1-0716-1060-2_3  0.398
2020 Kwak T, Wang F, Deng H, Condamine T, Kumar V, Perego M, Kossenkov A, Montaner LJ, Xu X, Xu W, Zheng C, Schuchter LM, Amaravadi RK, Mitchell TC, Karakousis GC, ... ... Gabrilovich DI, et al. Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer. Cell Reports. 33: 108571. PMID 33378668 DOI: 10.1016/j.celrep.2020.108571  0.356
2020 Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T, Lin C, Nefedova Y, Kossenkov A, Liu Q, Sreedhar S, Pass H, Roth J, Vogl T, Feldser D, Zhang R, ... ... Gabrilovich DI, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Science Translational Medicine. 12. PMID 33268511 DOI: 10.1126/scitranslmed.abb5817  0.376
2020 Douglass SM, Fane ME, Sanseviero E, Ecker BL, Kugel CH, Behera R, Kumar V, Tcyganov EN, Yin X, Liu Q, Chhabra Y, Alicea GM, Kuruvilla R, Gabrilovich DI, Weeraratna AT. Myeloid-derived suppressor cells are a major source of Wnt5A in the melanoma microenvironment and depend on Wnt5A for full suppressive activity. Cancer Research. PMID 33262126 DOI: 10.1158/0008-5472.CAN-20-1238  0.409
2020 Barnoud T, Leung JC, Leu JI, Basu S, Poli ANR, Parris JLD, Indeglia A, Martynyuk T, Good M, Gnanapradeepan K, Sanseviero E, Moeller R, Tang HY, Cassel J, Kossenkov AV, ... ... Gabrilovich DI, et al. A novel inhibitor of HSP70 induces mitochondrial toxicity and immune cell recruitment in tumors. Cancer Research. PMID 33023943 DOI: 10.1158/0008-5472.CAN-20-0397  0.368
2020 Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, Costich TL, Harro CM, Walrath J, Ming Q, Tcyganov E, Buras AL, Rigolizzo KE, Mandal G, Lajoie J, ... ... Gabrilovich DI, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science (New York, N.Y.). 369: 942-949. PMID 32820120 DOI: 10.1126/Science.Aay2767  0.517
2020 Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, ... ... Gabrilovich DI, et al. PPT1 Inhibition enhances the anti-tumor activity of anti-PD-1 antibody in melanoma. Jci Insight. PMID 32780726 DOI: 10.1172/Jci.Insight.133225  0.489
2020 Gabrilovich DI. All Myeloid-Derived Suppressor Cells Are Not Created Equal: How Gender Inequality Influences These Cells and Affects Cancer Therapy. Cancer Discovery. 10: 1100-1102. PMID 32747371 DOI: 10.1158/2159-8290.Cd-20-0494  0.43
2020 Ugolini A, Tyurin V, Tyurina Y, Tsyganov E, Donthireddy L, Kagan VE, Gabrilovich DI, Veglia F. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer. Jci Insight. PMID 32584791 DOI: 10.1172/jci.insight.138581  0.413
2020 Alicea GM, Rebecca VW, Goldman AR, Fane ME, Douglass SM, Behera R, Webster MR, Kugel CH, Ecker BL, Caino MC, Kossenkov AV, Tang HY, Frederick DT, Flaherty KT, Xu X, ... ... Gabrilovich DI, et al. Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2. Cancer Discovery. PMID 32499221 DOI: 10.1158/2159-8290.Cd-20-0329  0.316
2020 Hashimoto A, Fukumoto T, Zhang R, Gabrilovich D. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors. Cancer Immunology, Immunotherapy : Cii. PMID 32435850 DOI: 10.1007/s00262-020-02588-7  0.384
2020 Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B, Shrivastava IH, Tyurin VA, Ting HC, Wu YL, Gao Y, Shurin GV, ... ... Gabrilovich DI, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nature Chemical Biology. 16: 278-290. PMID 32080625 DOI: 10.1038/S41589-019-0462-8  0.329
2020 Atay C, Kwak T, Lavilla-Alonso S, Richards A, Moberg V, Pilon-Thomas S, Schell M, Messina JL, Rebecca VW, Zhang G, Weber JS, Herlyn M, Sarnaik AA, Gabrilovich DI. Abstract B41: BRAF targeting sensitizes resistant melanoma to cytotoxic T cells Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-B41  0.474
2020 Fuchs S, Alicea-Torres KM, Gabrilovich DI. Abstract A72: IFNAR1 signaling regulates PMN-MDSCs immune suppressive activity in cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A72  0.535
2020 Tcyganov EN, Gabrilovich DI. Abstract 6615: Peroxynitrite mediates immune escape of tumor cells from cytotoxic T cells in situ Immunology. 80: 6615-6615. DOI: 10.1158/1538-7445.Am2020-6615  0.52
2020 Douglass S, Fane M, Sanseviero E, Gabrilovich D, Weeraratna A. Abstract 2656: Myeloid derived Wnt5a influences the immune-dynamics of melanoma tumor microenvironment Tumor Biology. DOI: 10.1158/1538-7445.Am2020-2656  0.431
2019 Kagan VE, Tyurina YY, Sun WY, Vlasova LL, Dar H, Tyurin VA, Amoscato AA, Mallampalli R, van der Wel PCA, He RR, Shvedova AA, Gabrilovich D, Bayir H. Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death. Free Radical Biology & Medicine. PMID 31883467 DOI: 10.1016/J.Freeradbiomed.2019.12.028  0.319
2019 Seo JH, Chae YC, Kossenkov AV, Lee YG, Tang HY, Agarwal E, Gabrilovich DI, Languino LR, Speicher DW, Shastrula PK, Storaci AM, Ferrero S, Gaudioso G, Caroli M, Tosi D, et al. MFF REGULATION OF MITOCHONDRIAL CELL DEATH IS A THERAPEUTIC TARGET IN CANCER. Cancer Research. PMID 31582380 DOI: 10.1158/0008-5472.Can-19-1982  0.394
2019 Liu Y, Perego M, Xiao Q, He Y, Fu S, He J, Liu W, Li X, Tang Y, Li X, Yuan W, Zhou W, Wu F, Jia C, Cui Q, ... ... Gabrilovich DI, et al. Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice. The Journal of Clinical Investigation. PMID 31483289 DOI: 10.1172/Jci128164  0.417
2019 Fukumoto T, Fatkhutdinov N, Zundell JA, Tcyganov EN, Nacarelli T, Karakashev S, Wu S, Liu Q, Gabrilovich DI, Zhang R. HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer. Cancer Research. PMID 31311810 DOI: 10.1158/0008-5472.Can-19-1302  0.475
2019 Mastio J, Condamine T, Dominguez G, Kossenkov AV, Donthireddy L, Veglia F, Lin C, Wang F, Fu S, Zhou J, Viatour P, Lavilla-Alonso S, Polo AT, Tcyganov EN, Mulligan C, ... ... Gabrilovich DI, et al. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs. The Journal of Experimental Medicine. PMID 31239386 DOI: 10.1084/Jem.20181952  0.547
2019 Agarwal E, Altman BJ, Seo JH, Ghosh JC, Kossenkov AV, Tang HY, Krishn SR, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth. The Journal of Biological Chemistry. PMID 31097545 DOI: 10.1074/Jbc.Ac119.008656  0.461
2019 Agarwal E, Altman BJ, Seo JH, Bertolini I, Ghosh JC, Kaur A, Kossenkov AV, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. MYC REGULATION OF A MITOCHONDRIAL TRAFFICKING NETWORK MEDIATES TUMOR CELL INVASION AND METASTASIS. Molecular and Cellular Biology. PMID 31061095 DOI: 10.1128/Mcb.00109-19  0.401
2019 Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, ... ... Gabrilovich DI, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. PMID 30996346 DOI: 10.1038/S41586-019-1118-2  0.446
2019 Cao Y, Yang Q, Deng H, Tang J, Hu J, Liu H, Zhi M, Ye L, Zou B, Liu Y, Wei L, Gabrilovich DI, Wang H, Zhou J. Transcriptional factor ATF3 protects against colitis by regulating follicular helper T cells in Peyer's patches. Proceedings of the National Academy of Sciences of the United States of America. PMID 30862736 DOI: 10.1073/Pnas.1818164116  0.32
2019 Atay C, Kwak T, Lavilla-Alonso S, Donthireddy L, Richards AD, Moberg VE, Pilon-Thomas S, Schell MJ, Messina JL, Rebecca VW, Xiao M, Tan J, Zhang G, Weber JS, Herlyn M, ... ... Gabrilovich DI, et al. BRAF targeting sensitizes resistant melanoma to cytotoxic T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30765391 DOI: 10.1158/1078-0432.Ccr-18-2725  0.394
2019 Gabrilovich DI. Abstract IA10: PMN-MDSC and neutrophils: Tale of two cells in cancer Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Ia10  0.54
2019 Lin C, Herlihy SE, Li M, Deng H, Bernabei L, Gabrilovich DI, Vogl DT, Nefedova Y. Abstract 2103: NETs promote tumor resistance to anthracyclines Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2103  0.357
2018 Chiappori AA, Williams CC, Gray JE, Tanvetyanon T, Haura EB, Creelan BC, Thapa R, Chen DT, Simon GR, Bepler G, Gabrilovich DI, Antonia SJ. Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer. Cancer Immunology, Immunotherapy : Cii. PMID 30591959 DOI: 10.1007/S00262-018-2287-9  0.376
2018 Kim HR, Park SM, Seo SU, Jung I, Yoon HI, Gabrilovich DI, Cho BC, Seong SY, Ha SJ, Youn JI. The Ratio of Peripheral Regulatory T Cells to Lox-1 PMN-MDSC Predicts the Early Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer Patients. American Journal of Respiratory and Critical Care Medicine. PMID 30339766 DOI: 10.1164/Rccm.201808-1502Le  0.628
2018 Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, Lin C, Alicea-Torres K, Sehgal M, Nefedova Y, Zhou J, Languino LR, Clendenin C, Vonderheide RH, Mulligan C, ... ... Gabrilovich DI, et al. Unique pattern of neutrophil migration and function during tumor progression. Nature Immunology. PMID 30323345 DOI: 10.1038/S41590-018-0229-5  0.496
2018 Kumar S, Wilkes DW, Samuel N, Blanco MA, Nayak A, Alicea-Torres K, Gluck C, Sinha S, Gabrilovich D, Chakrabarti R. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer. The Journal of Clinical Investigation. PMID 30295647 DOI: 10.1172/Jci99673  0.51
2018 Hashimoto A, Gao C, Mastio J, Kossenkov A, Abrams SI, Purandare AV, Desilva H, Wee S, Hunt JT, Jure-Kunkel M, Gabrilovich DI. Inhibition of casein kinase 2 disrupts differentiation of myeloid cells in cancer and enhances the efficacy of immunotherapy in mice. Cancer Research. PMID 30139814 DOI: 10.1158/0008-5472.Can-18-1229  0.558
2018 Seo JH, Agarwal E, Bryant KG, Caino MC, Kim ET, Kossenkov AV, Tang HY, Languino LR, Gabrilovich DI, Cohen AR, Speicher DW, Altieri DC. Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics And Tumor Cell Movements. Cancer Research. PMID 29898993 DOI: 10.1158/0008-5472.Can-18-0595  0.408
2018 Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, ... ... Gabrilovich D, et al. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29898988 DOI: 10.1158/1078-0432.Ccr-18-1116  0.36
2018 Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine. PMID 29686425 DOI: 10.1038/S41591-018-0014-X  0.441
2018 Tang CA, Chang S, Hashimoto A, Chen YJ, Kang CW, Mato AR, Del Valle JR, Gabrilovich D, Hu CA. Secretory IgM exacerbates tumor progression by inducing accumulations of MDSCs in mice. Cancer Immunology Research. PMID 29650518 DOI: 10.1158/2326-6066.Cir-17-0582  0.47
2018 Tcyganov E, Mastio J, Chen E, Gabrilovich DI. Plasticity of myeloid-derived suppressor cells in cancer. Current Opinion in Immunology. 51: 76-82. PMID 29547768 DOI: 10.1016/J.Coi.2018.03.009  0.532
2018 Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nature Immunology. PMID 29348500 DOI: 10.1038/S41590-017-0022-X  0.453
2018 He YM, Li X, Perego M, Nefedova Y, Kossenkov AV, Jensen EA, Kagan V, Liu YF, Fu SY, Ye QJ, Zhou YH, Wei L, Gabrilovich DI, Zhou J. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nature Medicine. PMID 29334374 DOI: 10.1038/nm.4467  0.341
2018 Dominguez G, Sholevar C, Polo A, Roop J, Campisi A, Gabrilovich D, Rauscher FJ, Kumar A. The coupling of MDSCs with a computational analytic method to detect solid tumors. Journal of Clinical Oncology. 36: 24-24. DOI: 10.1200/Jco.2018.36.5_Suppl.24  0.421
2018 Gandhi L, Janne PA, Opyrchal M, Ramalingam SS, Rybkin II, Hafez N, Raez LE, Gabrilovich D, Wang F, Ordentlich P, Brouwer S, Sankoh S, Schmidt EV, Meyers ML, Hellmann MD. Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy. Journal of Clinical Oncology. 36: 9036-9036. DOI: 10.1200/Jco.2018.36.15_Suppl.9036  0.327
2018 Gabrilovich D. Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Bs1-2  0.57
2018 Tolcher AW, Meyers ML, Gabrilovich D, Wang F, Trepel J, Lee M, Schmitt E, Quaranto C, Sankoh S, Tamang D, Ordentlich P. Abstract CT179: Safety, efficacy, and immune correlates of alternative doses and schedules of entinostat combined with pembrolizumab in patients with advanced solid tumors - results from SNDX-275-0141 phase I trial Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct179  0.409
2018 Veglia F, Tyurin VA, Kagan VE, Gabrilovich D. Abstract 5133: Lipids and suppressive functions of MDSC in cancer Cancer Research. 78: 5133-5133. DOI: 10.1158/1538-7445.Am2018-5133  0.433
2018 Tang C, Chang S, Hashimoto A, Chen Y, Kang CW, Mato A, Valle JD, Gabrilovich D, Hu CA. Abstract 4756: Secretory IgM exacerbates tumor progression by inducing accumulations of myeloid-derived suppressor cells in mice Cancer Research. 78: 4756-4756. DOI: 10.1158/1538-7445.Am2018-4756  0.477
2018 Dominguez GA, Maslar K, Polo A, Sholevar C, Campisi A, Roop J, Gabrilovich D, Rauscher F, Kumar A. Abstract 1582: The coupling of MDSCs with a computational neural network (NN) to detect solid tumors Cancer Research. 78: 1582-1582. DOI: 10.1158/1538-7445.Am2018-1582  0.423
2018 Atay C, Lavilla-Alonso S, Gabrilovich D. Abstract 1543: Upregulation of mannose 6-phosphate receptor (MPR) has a potential to increase the efficacy of combined therapy for melanoma patients Cancer Research. 78: 1543-1543. DOI: 10.1158/1538-7445.Am2018-1543  0.505
2018 Tcyganov EN, Gabrilovich DI. Abstract 1008: Peroxynitrite mediates the resistance of tumor cells to cytotoxic T cells by altering the MHC1-peptide repertoire on tumor cells Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1008  0.493
2017 Zhou J, Nefedova Y, Lei A, Gabrilovich D. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Seminars in Immunology. PMID 29254756 DOI: 10.1016/j.smim.2017.12.004  0.346
2017 Veglia F, Tyurin VA, Mohammadyani D, Blasi M, Duperret EK, Donthireddy L, Hashimoto A, Kapralov A, Amoscato A, Angelini R, Patel S, Alicea-Torres K, Weiner D, Murphy ME, Klein-Seetharaman J, ... ... Gabrilovich DI, et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nature Communications. 8: 2122. PMID 29242535 DOI: 10.1038/S41467-017-02186-9  0.487
2017 Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, Hashimoto A, Vonteddu P, Behera R, Goins MA, Mulligan C, Nam B, Hockstein N, Denstman F, Shakamuri S, ... ... Gabrilovich DI, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 32: 654-668.e5. PMID 29136508 DOI: 10.1016/J.Ccell.2017.10.005  0.464
2017 Caino MC, Seo JH, Wang Y, Rivadeneira DB, Gabrilovich DI, Kim ET, Weeraratna AT, Languino LR, Altieri DC. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. The Journal of Clinical Investigation. PMID 28891816 DOI: 10.1172/JCI93172  0.369
2017 Orillion A, Hashimoto A, Damayanti NP, Shen L, Adelaiye-Ogala R, Arisa S, Chintala S, Ordentlich P, Kao C, Elzey B, Gabrilovich D, Pili R. Entinostat neutralizes myeloid derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28698201 DOI: 10.1158/1078-0432.Ccr-17-0741  0.486
2017 Gabrilovich D, Ferris RL. Editorial overview: Many shades of grey: how immune response is regulated by tumors. Current Opinion in Immunology. 45: ix-xi. PMID 28554483 DOI: 10.1016/J.Coi.2017.05.003  0.445
2017 Veglia F, Gabrilovich DI. Dendritic cells in cancer: the role revisited. Current Opinion in Immunology. 45: 43-51. PMID 28192720 DOI: 10.1016/j.coi.2017.01.002  0.42
2017 Gabrilovich DI. Myeloid-Derived Suppressor Cells. Cancer Immunology Research. 5: 3-8. PMID 28052991 DOI: 10.1158/2326-6066.Cir-16-0297  0.579
2017 Johnson ML, Gonzalez R, Opyrchal M, Gabrilovich D, Ordentlich P, Brouwer S, Sankoh S, Schmidt EV, Meyers ML, Agarwala SS. ENCORE 601: A phase II study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with melanoma. Journal of Clinical Oncology. 35: 9529-9529. DOI: 10.1200/Jco.2017.35.15_Suppl.9529  0.317
2017 Tang C, Chang S, Paton A, Paton J, Gabrilovich D, Ploegh H, Valle JD, Hu CA. Abstract LB-336: Specific serine phosphorylation of IRE-1 controls enhanced splicing of XBP-1 and regulated IRE-1-dependent decay (RIDD) Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-336  0.372
2017 Dominguez GA, Condamine T, Mony S, Hashimoto A, Wang F, Liu Q, Forero A, Bendell JC, Witt R, Hockstein N, Kumar P, Gabrilovich DI. Abstract CT095: The selective targeting of myeloid-derived suppressor cells in cancer patients using an agonistic TRAIL-R2 antibody Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct095  0.42
2017 Hashimoto A, Kumar V, Ordentlich P, Gabrilovich DI. Abstract 5595: HDAC inhibitor Entinostat disrupts function of PMN-MDSC Cancer Research. 77: 5595-5595. DOI: 10.1158/1538-7445.Am2017-5595  0.551
2017 Herlihy S, Lin C, Ozeriva M, Garfall A, Vogl D, Gabrilovich D, Nefedova Y. Abstract 3980: Ly6G+ neutrophils and polymorphonuclear myeloid derived suppressor cells promote the survival of tumor cells Cancer Research. 77: 3980-3980. DOI: 10.1158/1538-7445.Am2017-3980  0.58
2017 Rivera CA, Dominguez GA, Tomov V, Falk GW, Ginsberg GG, Gabrilovich D, Rustgi AK, Lynch JP. Identification of Myeloid Derived Suppressor Cells in the Barrett’s Metaplasia to Esophageal Adenocarcinoma Sequence Gastroenterology. 152: S234. DOI: 10.1016/S0016-5085(17)31071-5  0.367
2016 Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, ... ... Gabrilovich DI, et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Science Immunology. 1. PMID 28417112 DOI: 10.1126/Sciimmunol.Aaf8943  0.673
2016 Dominguez G, Condamine TC, Mony S, Hashimoto A, Wang F, Liu Q, Forero A, Bendell JC, Witt R, Hockstein N, Kumar P, Gabrilovich D. Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27965309 DOI: 10.1158/1078-0432.Ccr-16-1784  0.377
2016 Sayeed A, Lu H, Liu Q, Deming Ii D, Duffy A, McCue P, Dicker AP, Davis RJ, Gabrilovich D, Rodeck U, Altieri DC, Languino LR. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation. Oncotarget. PMID 27438371 DOI: 10.18632/Oncotarget.10522  0.379
2016 Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature Communications. 7: 12150. PMID 27381735 DOI: 10.1038/Ncomms12150  0.471
2016 Kumar V, Cheng P, Condamine T, Mony S, Languino LR, McCaffrey JC, Hockstein N, Guarino M, Masters G, Penman E, Denstman F, Xu X, Altieri DC, Du H, Yan C, ... Gabrilovich DI, et al. CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation. Immunity. 44: 303-15. PMID 26885857 DOI: 10.1016/J.Immuni.2016.01.014  0.507
2016 Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends in Immunology. PMID 26858199 DOI: 10.1016/J.It.2016.01.004  0.499
2016 Johnson ML, Adjei AA, Ramalingam SS, Janne PA, Dominguez G, Gabrilovich D, Deleon L, Hasapidis JL, Diede SJ, Ordentlich P, Hellmann MD. Preliminary results of ENCORE 601, a phase 1b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 34: e20659-e20659. DOI: 10.1200/Jco.2016.34.15_Suppl.E20659  0.383
2015 Ramachandran IR, Condamine T, Lin C, Herlihy SE, Garfall A, Vogl DT, Gabrilovich DI, Nefedova Y. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy. Cancer Letters. PMID 26639197 DOI: 10.1016/J.Canlet.2015.10.040  0.475
2015 Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. Journal of Leukocyte Biology. 98: 913-22. PMID 26337512 DOI: 10.1189/Jlb.4Ri0515-204R  0.547
2015 Gabrilovich D, Nefedova Y. ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells. Cancer Cell. 28: 147-9. PMID 26267530 DOI: 10.1016/J.Ccell.2015.07.007  0.528
2015 Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, Munn DH, Murphy WJ, Brickey WJ, Serody JS, Gabrilovich DI, Bronte V, Murray PJ, Ting JP, Zeiser R, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 126: 1621-8. PMID 26265697 DOI: 10.1182/Blood-2015-03-634691  0.378
2015 Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. The Journal of Clinical Investigation. 125: 3356-64. PMID 26168215 DOI: 10.1172/Jci80005  0.546
2015 Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, ... ... Gabrilovich DI, et al. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 4: e998538. PMID 26137416 DOI: 10.1080/2162402X.2014.998538  0.457
2015 Gabrilovich D. Fatal attraction: How macrophages participate in tumor metastases Journal of Experimental Medicine. 212: 976-976. PMID 26122939 DOI: 10.1084/Jem.2127Insight1  0.435
2015 Locke FL, Menges M, Veerapathran A, Coppola D, Gabrilovich D, Anasetti C. Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. Journal For Immunotherapy of Cancer. 3: 20. PMID 25992291 DOI: 10.1186/S40425-015-0065-1  0.405
2015 Ortiz ML, Kumar V, Martner A, Mony S, Donthireddy L, Condamine T, Seykora J, Knight SC, Malietzis G, Lee GH, Moorghen M, Lenox B, Luetteke N, Celis E, Gabrilovich D. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. The Journal of Experimental Medicine. 212: 351-67. PMID 25667306 DOI: 10.1084/Jem.20140835  0.528
2015 Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annual Review of Medicine. 66: 97-110. PMID 25341012 DOI: 10.1146/Annurev-Med-051013-052304  0.724
2015 Sahakian E, Powers JJ, Chen J, Deng SL, Cheng F, Distler A, Woods DM, Rock-Klotz J, Sodre AL, Youn JI, Woan KV, Villagra A, Gabrilovich D, Sotomayor EM, Pinilla-Ibarz J. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Molecular Immunology. 63: 579-85. PMID 25155994 DOI: 10.1016/J.Molimm.2014.08.002  0.706
2015 Ramachandran I, Lin C, Condamine T, Ozerova M, Garfall A, Vogl D, Gabrilovich D, Nefedova Y. Abstract 5020: Neutrophils in the bone marrow niche promote multiple myeloma chemoresistance Cancer Research. 75: 5020-5020. DOI: 10.1158/1538-7445.Am2015-5020  0.51
2015 Veglia F, Tyurin V, Kagan V, Gabrilovich D. Abstract 467: Oxidized lipids contribute to the suppression function of myeloid derived suppressor cells in cancer Cancer Research. 75: 467-467. DOI: 10.1158/1538-7445.Am2015-467  0.465
2015 Marvel DM, Gabrilovich D. Abstract 4051: Protection from CTL mediated killing by iNOS expression in a mouse model of melanoma Cancer Research. 75: 4051-4051. DOI: 10.1158/1538-7445.Am2015-4051  0.509
2015 Condamine TC, Kumar V, Gabrilovich DI. Abstract 3176: Linking suppressive activity and ER-Stress in Myeloid Derived Suppressor Cells Cancer Research. 75: 3176-3176. DOI: 10.1158/1538-7445.Am2015-3176  0.479
2015 Mastio J, Condamine T, Gabrilovich D. Abstract 3174: Retinoblastoma protein 1 implication in the monocytic - granulocytic transition Cancer Research. 75: 3174-3174. DOI: 10.1158/1538-7445.Am2015-3174  0.52
2015 Kumar V, Cheng P, Condamine T, Gabrilovich D. Abstract 2343: Tumor microenvironment regulates the fate of myeloid cells by controlling STAT3 activity Cancer Research. 75: 2343-2343. DOI: 10.1158/1538-7445.Am2015-2343  0.561
2015 Lavilla-Alonso S, Brekken R, Gabrilovich D. Abstract 1337: Up-regulation of mannose 6-phosphate receptor induced by BRAF inhibitor PLX4720 is linked to phosphatidylserine externalization and shows positive effects for combination therapies Cancer Research. 75: 1337-1337. DOI: 10.1158/1538-7445.Am2015-1337  0.461
2014 Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Gabrilovich DI, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998  0.433
2014 Gabrilovich DI. Editorial: The intricacy of choice: can bacteria decide what type of myeloid cells to stimulate? Journal of Leukocyte Biology. 96: 671-4. PMID 25360040 DOI: 10.1189/Jlb.4Ce0514-271R  0.391
2014 Condamine T, Gabrilovich DI. Can the suppressive activity of myeloid-derived suppressor cells be "chop"ped? Immunity. 41: 341-2. PMID 25238087 DOI: 10.1016/J.Immuni.2014.08.016  0.485
2014 Kumar V, Gabrilovich DI. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment. Immunology. 143: 512-9. PMID 25196648 DOI: 10.1111/Imm.12380  0.476
2014 Yang Q, Shi M, Shen Y, Cao Y, Zuo S, Zuo C, Zhang H, Gabrilovich DI, Yu Y, Zhou J. COX-1-derived thromboxane A2 plays an essential role in early B-cell development via regulation of JAK/STAT5 signaling in mouse. Blood. 124: 1610-21. PMID 25030064 DOI: 10.1182/Blood-2014-03-559658  0.384
2014 Kim S, Ramakrishnan R, Lavilla-Alonso S, Chinnaiyan P, Rao N, Fowler E, Heine J, Gabrilovich DI. Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice. Cancer Immunology, Immunotherapy : Cii. 63: 1009-21. PMID 24943275 DOI: 10.1007/S00262-014-1573-4  0.52
2014 Condamine T, Kumar V, Ramachandran IR, Youn JI, Celis E, Finnberg N, El-Deiry WS, Winograd R, Vonderheide RH, English NR, Knight SC, Yagita H, McCaffrey JC, Antonia S, Hockstein N, ... ... Gabrilovich DI, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. The Journal of Clinical Investigation. 124: 2626-39. PMID 24789911 DOI: 10.1172/Jci74056  0.699
2014 Ortiz ML, Lu L, Ramachandran I, Gabrilovich DI. Myeloid-derived suppressor cells in the development of lung cancer. Cancer Immunology Research. 2: 50-8. PMID 24778162 DOI: 10.1158/2326-6066.Cir-13-0129  0.448
2014 Senesac J, Gabrilovich D, Pirruccello S, Talmadge JE. Dendritic cells transfected with adenoviral vectors as vaccines Methods in Molecular Biology. 1139: 97-118. PMID 24619674 DOI: 10.1007/978-1-4939-0345-0_10  0.41
2014 Ramakrishnan R, Tyurin VA, Tuyrin VA, Veglia F, Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM, Klein-Seetharaman J, Celis E, Kagan VE, Gabrilovich DI. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. Journal of Immunology (Baltimore, Md. : 1950). 192: 2920-31. PMID 24554775 DOI: 10.4049/Jimmunol.1302801  0.426
2014 Farren MR, Carlson LM, Netherby CS, Lindner I, Li PK, Gabrilovich DI, Abrams SI, Lee KP. Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance. Science Signaling. 7: ra16. PMID 24550541 DOI: 10.1126/Scisignal.2004656  0.566
2014 Cheng P, Kumar V, Liu H, Youn JI, Fishman M, Sherman S, Gabrilovich D. Effects of notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Research. 74: 141-52. PMID 24220241 DOI: 10.1158/0008-5472.Can-13-1686  0.695
2014 Liu H, Ramachandran I, Gabrilovich DI. Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor. Immunology and Cell Biology. 92: 200-3. PMID 24165981 DOI: 10.1038/Icb.2013.65  0.443
2014 Cao W, Ramakrishnan R, Tuyrin VA, Veglia F, Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM, Klein-Seetharaman J, Celis E, Kagan VE, Gabrilovich DI. Correction: Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer The Journal of Immunology. 192: 4935-4935. DOI: 10.4049/Jimmunol.1490017  0.339
2014 Raj SK, Indelicato DJ, Chiappori A, Conley AP, Gonzales R, Heysec R, Letson DD, Gabrilovich D, Bui MM, Finklestein S, Antonia SJ. Neoadjuvant administration of radiation therapy and intratumoral autologous dendritic cells in patients with localized high-risk soft tissue sarcomas. Journal of Clinical Oncology. 32: 10519-10519. DOI: 10.1200/Jco.2014.32.15_Suppl.10519  0.489
2014 Yopp A, Kallinteris N, Huang X, Shan J, Menander K, Freimark B, Hutchins J, King S, Gabrilovich DI, Brekken R. Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment Journal For Immunotherapy of Cancer. 2: P266. DOI: 10.1186/2051-1426-2-S3-P266  0.534
2014 Youn J, Lee K, Lee H, Gabrilovich DI. Loss of Rb1 by epigenetic modification regulates expansion of MDSC in cancer Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P241  0.486
2014 Yopp A, Kallinteris N, Huang X, Shan J, Menander K, Hutchins J, King S, Xu X, Gabrilovich D, Brekken R. Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma Journal For Immunotherapy of Cancer. 2: P214. DOI: 10.1186/2051-1426-2-S3-P214  0.386
2014 Ramachandran IR, Lin C, Chase T, Gabrilovich D, Nefedova Y. A Novel Agent Tasquinimod Demonstrates a Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma Blood. 124: 5729-5729. DOI: 10.1182/Blood.V124.21.5729.5729  0.487
2014 Ramachandran I, Condamine T, Gabrilovich D, Nefedova Y. Abstract 164: Bone marrow myeloid cells promote multiple myeloma chemoresistance by DNA mediated signaling Cancer Research. 74: 164-164. DOI: 10.1158/1538-7445.Am2014-164  0.518
2014 Mohammadyani D, Tyurin VA, Amoscato AA, Gabrilovich DI, Klein-Seetharaman J, Kagan VE. Computational Approaches to Understanding the Role of Oxidized Tri-Aclyglycerols in Suppression of Antigen Cross-Presentation in Cancer Biophysical Journal. 106: 805a-806a. DOI: 10.1016/J.Bpj.2013.11.4416  0.368
2014 Condamine T, Ramachandran IR, Gabrilovich DI. S100A9, inflammation, and regulation of immune suppression in cancer Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 295-310. DOI: 10.1007/978-1-4899-8056-4_10  0.45
2014 Gabrilovich DI, Hurwitz AA. Tumor-induced immune suppression: Mechanisms and therapeutic reversal Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 1-464. DOI: 10.1007/978-1-4899-8056-4  0.346
2013 Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, ... ... Gabrilovich DI, et al. Induction of myelodysplasia by myeloid-derived suppressor cells. The Journal of Clinical Investigation. 123: 4595-611. PMID 24216507 DOI: 10.1172/Jci67580  0.668
2013 Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nature Reviews. Cancer. 13: 739-52. PMID 24060865 DOI: 10.1038/Nrc3581  0.479
2013 Liu H, Zhou J, Cheng P, Ramachandran I, Nefedova Y, Gabrilovich DI. Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis. Journal of Immunology (Baltimore, Md. : 1950). 191: 1916-26. PMID 23833236 DOI: 10.4049/Jimmunol.1300714  0.407
2013 Nagaraj S, Youn JI, Gabrilovich DI. Reciprocal relationship between myeloid-derived suppressor cells and T cells. Journal of Immunology (Baltimore, Md. : 1950). 191: 17-23. PMID 23794702 DOI: 10.4049/Jimmunol.1300654  0.735
2013 Iclozan C, Antonia S, Chiappori A, Chen DT, Gabrilovich D. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunology, Immunotherapy : Cii. 62: 909-18. PMID 23589106 DOI: 10.1007/S00262-013-1396-8  0.413
2013 Youn JI, Gabrilovich DI. New roles of Rb1 in expansion of MDSCs in cancer. Cell Cycle (Georgetown, Tex.). 12: 1329-30. PMID 23588070 DOI: 10.4161/Cc.24577  0.751
2013 Ramachandran IR, Martner A, Pisklakova A, Condamine T, Chase T, Vogl T, Roth J, Gabrilovich D, Nefedova Y. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. Journal of Immunology (Baltimore, Md. : 1950). 190: 3815-23. PMID 23460744 DOI: 10.4049/Jimmunol.1203373  0.483
2013 Gabrilovich DI. Applying pressure on macrophages. Immunity. 38: 205-6. PMID 23438819 DOI: 10.1016/J.Immuni.2013.02.004  0.371
2013 Ramakrishnan R, Gabrilovich DI. Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer. Cancer Immunology, Immunotherapy : Cii. 62: 405-10. PMID 23423351 DOI: 10.1007/S00262-012-1390-6  0.344
2013 Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S, Anasetti C, Gabrilovich D, Yu XZ. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 692-702. PMID 23376089 DOI: 10.1016/J.Bbmt.2013.01.008  0.474
2013 Youn JI, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, Sarnaik A, Horna P, Sotomayor E, Gabrilovich DI. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nature Immunology. 14: 211-20. PMID 23354483 DOI: 10.1038/Ni.2526  0.698
2013 Ramakrishnan R, Gabrilovich DI. The role of mannose-6-phosphate receptor and autophagy in influencing the outcome of combination therapy. Autophagy. 9: 615-6. PMID 23324210 DOI: 10.4161/Auto.23485  0.43
2013 Gabrilovich D. Abstract IA7: Regulation of myeloid-derived suppressor cells in tumor micro-environment. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-Ia7  0.593
2013 Youn J, Kumar V, Collazo M, Gabrilovich DI. Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Cancer Research. 73: 1515-1515. DOI: 10.1158/1538-7445.Am2013-1515  0.707
2012 Ramakrishnan R, Huang C, Cho HI, Lloyd M, Johnson J, Ren X, Altiok S, Sullivan D, Weber J, Celis E, Gabrilovich DI. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy. Cancer Research. 72: 5483-93. PMID 22942258 DOI: 10.1158/0008-5472.Can-12-2236  0.509
2012 Lu T, Gabrilovich DI. Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4877-82. PMID 22718858 DOI: 10.1158/1078-0432.Ccr-11-2939  0.583
2012 Finkelstein SE, Rodriguez F, Dunn M, Farmello MJ, Smilee R, Janssen W, Kang L, Chuang T, Seigne J, Pow-Sang J, Torres-Roca JF, Heysek R, Biagoli M, Shankar R, Scott J, ... ... Gabrilovich D, et al. Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy. Immunotherapy. 4: 373-82. PMID 22512631 DOI: 10.2217/Imt.12.24  0.444
2012 Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nature Reviews. Immunology. 12: 253-68. PMID 22437938 DOI: 10.1038/Nri3175  0.488
2012 Finkelstein SE, Fishman M, Conley AP, Gabrilovich D, Antonia S, Chiappori A. Cellular immunotherapy for soft tissue sarcomas. Immunotherapy. 4: 283-90. PMID 22401634 DOI: 10.2217/Imt.12.3  0.324
2012 Nagaraj S, Gabrilovich DI. Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells. Seminars in Cancer Biology. 22: 282-8. PMID 22313876 DOI: 10.1016/J.Semcancer.2012.01.010  0.454
2012 Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI. Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Research. 72: 928-38. PMID 22237629 DOI: 10.1158/0008-5472.Can-11-2863  0.69
2012 Huang C, Ramakrishnan R, Trkulja M, Ren X, Gabrilovich DI. Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines. Cancer Immunology, Immunotherapy : Cii. 61: 573-9. PMID 22223258 DOI: 10.1007/S00262-011-1198-9  0.478
2012 Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Journal of Leukocyte Biology. 91: 167-81. PMID 21954284 DOI: 10.1189/Jlb.0311177  0.678
2012 Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, ... ... Gabrilovich DI, et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients International Journal of Radiation Oncology Biology Physics. 82: 924-932. PMID 21398051 DOI: 10.1016/J.Ijrobp.2010.12.068  0.514
2012 Iclozan C, Gabrilovich DI. Recent Advances in Immunotherapy of Lung Cancer Journal of Lung Cancer. 11: 1. DOI: 10.6058/Jlc.2012.11.1.1  0.344
2012 Sahakian E, Powers J, Horna P, Rock-Klotz J, Deng S, Woods DM, Nguyen M, Woan KV, Cheng F, Villagra A, Gabrilovich D, Sotomayor EM, Pinilla-Ibarz J. Novel Role of Histone Deacetylase 11 (HDAC11) in Hematopoiesis Blood. 120: 4728-4728. DOI: 10.1182/Blood.V120.21.4728.4728  0.432
2012 Ramachandran IR, Martner A, Condamine TC, Pisklakova A, Chase T, Gabrilovich D, Nefedova Y. Accumulation of Myeloid-Derived Suppressor Cells in Bone Marrow in Multiple Myeloma Induces Tumor-Specific Immune Suppression and Promotes Tumor Growth Blood. 120: 3954-3954. DOI: 10.1182/Blood.V120.21.3954.3954  0.55
2012 Wang D, Yu Y, Semple KM, Haarberg KM, Fu J, Kaosaard K, Anasetti C, Srinivas N, Gabrilovich D, Yu X. Dynamic Changes and Impact of Myeloid Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice. Blood. 120: 2999-2999. DOI: 10.1182/Blood.V120.21.2999.2999  0.451
2012 Youn J, Collazo M, Kumar V, Gabrilovich DI. Abstract 5411: Rb1 controls the differentiation of myeloid-derived suppressor cells subsets Immunology. 72: 5411-5411. DOI: 10.1158/1538-7445.Am2012-5411  0.638
2012 Condamine T, Cheng P, Youn J, Ortiz ML, Vogl T, Roth J, Gabrilovich DI. Abstract 5399: S100A9 drives MDSC migration and contributes to tumor progression by inhibiting the immune response Cancer Research. 72: 5399-5399. DOI: 10.1158/1538-7445.Am2012-5399  0.737
2012 Cao W, Koomen JM, Gabrilovich DI, Tyurin VA, Kagan VE. Abstract 3530: Lipid accumulation inhibits DC ability for cross-presentation of antigens in tumor-bearing mice Cancer Research. 72: 3530-3530. DOI: 10.1158/1538-7445.Am2012-3530  0.467
2012 Gabrilovich D, Ramakrishnan R, Huang C. Abstract IA18: Molecular mechanisms regulating synergistic effect of immunotherapy and chemotherapy of cancer Clinical Cancer Research. 18: IA18-IA18. DOI: 10.1158/1078-0432.12Aacriaslc-Ia18  0.55
2011 Finkelstein SE, Gabrilovich D, Rodriguez FA, Chuang T, Kang L, Torres-Roca J, Heysek R, Pow-Sang JM, Antonia S, Fishman MN. Know when to say when: Serial assessment of apoptosis and lymphocyte infiltrates with combined intraprostatic autologous dendritic cell immunotherapy/radiation therapy in high-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 149. PMID 27968604 DOI: 10.1200/Jco.2011.29.7_Suppl.149  0.487
2011 Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, Libby P, Hansson GK, Shortman K, Dong C, Gabrilovich D, GabryÅ¡ová L, Howes A, O'Garra A. Highlights of 10 years of immunology in Nature Reviews Immunology. Nature Reviews. Immunology. 11: 693-702. PMID 21941295 DOI: 10.1038/Nri3063  0.405
2011 Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. The Journal of Clinical Investigation. 121: 4015-29. PMID 21911941 DOI: 10.1172/Jci45862  0.725
2011 Tyurin VA, Cao W, Tyurina YY, Gabrilovich DI, Kagan VE. Mass-spectrometric characterization of peroxidized and hydrolyzed lipids in plasma and dendritic cells of tumor-bearing animals. Biochemical and Biophysical Research Communications. 413: 149-53. PMID 21872574 DOI: 10.1016/J.Bbrc.2011.08.074  0.536
2011 Cao M, Xu Y, Youn JI, Cabrera R, Zhang X, Gabrilovich D, Nelson DR, Liu C. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 598-608. PMID 21321535 DOI: 10.1038/Labinvest.2010.205  0.717
2011 Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends in Immunology. 32: 19-25. PMID 21067974 DOI: 10.1016/J.It.2010.10.002  0.54
2011 Ramakrishnan R, Gabrilovich DI. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer. Cancer Immunology, Immunotherapy : Cii. 60: 419-23. PMID 20976448 DOI: 10.1007/S00262-010-0930-1  0.359
2011 Wei S, Chen X, Zhou J, Zhang L, Fortenbery NR, Rasche SS, McGraw K, Eksioglu EA, Epling-Burnette P, Djeu JY, Gabrilovich DI, List AF. Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC) Blood. 118: 788-788. DOI: 10.1182/Blood.V118.21.788.788  0.419
2011 Cao W, Gabrilovich D. Abstract 3649: Contribution of fatty acid accumulation to myeloid-derived suppressor cell function in cancer Cancer Research. 71: 3649-3649. DOI: 10.1158/1538-7445.Am2011-3649  0.541
2011 Condamine T, Cheng P, Youn J, Ortiz ML, Vogl T, Roth J, Gabrilovich DI. Abstract 3648: S100A9 play a role in MDSC expansion and migration but not in their activation Cancer Research. 71: 3648-3648. DOI: 10.1158/1538-7445.Am2011-3648  0.747
2011 Youn J, Collazo MM, Gabrilovich D. Abstract 3647: Characterization of the relationship between mature neutrophils and tumor associated granulocytic myeloid-derived suppressor cells Cancer Research. 71: 3647-3647. DOI: 10.1158/1538-7445.Am2011-3647  0.669
2011 Ortiz ML, Cheng P, Luetteke N, Youn J, Gabrilovich DI. Abstract 3646: The role of myeloid-derived suppressor cells in tumor development Cancer Research. 71: 3646-3646. DOI: 10.1158/1538-7445.Am2011-3646  0.671
2011 Talmadge JE, Gabrilovich DI. Conference on regulatory myeloid cells International Immunopharmacology. 11: 779. DOI: 10.1016/j.intimp.2011.04.009  0.359
2010 Li M, Chen F, Clifton N, Sullivan DM, Dalton WS, Gabrilovich DI, Nefedova Y. Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect. Molecular Cancer Therapeutics. 9: 3200-9. PMID 21159606 DOI: 10.1158/1535-7163.Mct-10-0372  0.41
2010 Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. European Journal of Immunology. 40: 2969-75. PMID 21061430 DOI: 10.1002/Eji.201040895  0.716
2010 Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. The Journal of Experimental Medicine. 207: 2439-53. PMID 20876310 DOI: 10.1084/Jem.20100587  0.808
2010 Finkelstein SE, Carey T, Fricke I, Yu D, Goetz D, Gratz M, Dunn M, Urbas P, Daud A, DeConti R, Antonia S, Gabrilovich D, Fishman M. Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 817-27. PMID 20842055 DOI: 10.1097/Cji.0B013E3181Ecccad  0.315
2010 Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer Journal (Sudbury, Mass.). 16: 348-53. PMID 20693846 DOI: 10.1097/Ppo.0B013E3181Eb3358  0.49
2010 Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho HI, Celis E, Lennox B, Knight SC, Padhya T, McCaffrey TV, McCaffrey JC, Antonia S, ... ... Gabrilovich DI, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nature Medicine. 16: 880-6. PMID 20622859 DOI: 10.1038/Nm.2172  0.464
2010 Chiappori AA, Soliman H, Janssen WE, Antonia SJ, Gabrilovich DI. INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. Expert Opinion On Biological Therapy. 10: 983-91. PMID 20420527 DOI: 10.1517/14712598.2010.484801  0.466
2010 Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho HI, Antonia S, Altiok S, Celis E, Gabrilovich DI. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. The Journal of Clinical Investigation. 120: 1111-24. PMID 20234093 DOI: 10.1172/Jci40269  0.536
2010 Nagaraj S, Youn JI, Weber H, Iclozan C, Lu L, Cotter MJ, Meyer C, Becerra CR, Fishman M, Antonia S, Sporn MB, Liby KT, Rawal B, Lee JH, Gabrilovich DI. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1812-23. PMID 20215551 DOI: 10.1158/1078-0432.Ccr-09-3272  0.703
2010 Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunological Reviews. 234: 105-19. PMID 20193015 DOI: 10.1111/J.0105-2896.2009.00871.X  0.422
2010 Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 3106-16. PMID 20142361 DOI: 10.4049/Jimmunol.0902661  0.433
2010 Ramakrishnan R, Assudani D, Celis E, Gabrilovich D. Abstract 5599: Novel mechanism of synergistic effect of cancer immunotherapy and chemotherapy Cancer Research. 70: 5599-5599. DOI: 10.1158/1538-7445.Am10-5599  0.575
2010 Iclozan C, Finkelstein SE, Ahmed J, Bui MM, Cotter MJ, Ramakrishnan R, Cheong D, Gonzalez RJ, Heysek RV, Lenox BC, Sondak VK, Szekely RR, Zager JS, Letson GD, Antonia SJ, ... Gabrilovich DI, et al. Abstract 2411: Intratumoral dendritic cell vaccine as neo-adjuvant immunotherapy of high-risk soft tissue sarcoma patients undergoing external beam radiation therapy (EBRT): Prospective phase I/II clinical trial Cancer Research. 70: 2411-2411. DOI: 10.1158/1538-7445.Am10-2411  0.494
2010 Iclozan C, Cotter M, Ramakrishnan R, Lenox B, Bui M, Letson G, Antonia S, Gabrilovich D, Finkelstein S. Myeloid-derived Suppressor Cell and Regulatory T Cell Immune Monitoring of Soft Tissue Sarcoma Patients Undergoing Combination External Beam Radiation and Intratumoral Dendritic Cell Vaccination International Journal of Radiation Oncology*Biology*Physics. 78: S657-S658. DOI: 10.1016/J.Ijrobp.2010.07.1530  0.429
2009 Nagaraj S, Collazo M, Corzo CA, Youn JI, Ortiz M, Quiceno D, Gabrilovich DI. Regulatory myeloid suppressor cells in health and disease. Cancer Research. 69: 7503-6. PMID 19752086 DOI: 10.1158/0008-5472.Can-09-2152  0.769
2009 Zhou J, Cheng P, Youn JI, Cotter MJ, Gabrilovich DI. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity. 30: 845-59. PMID 19523851 DOI: 10.1016/J.Immuni.2009.03.021  0.621
2009 Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 5693-701. PMID 19380816 DOI: 10.4049/Jimmunol.0900092  0.764
2009 Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews. Immunology. 9: 162-74. PMID 19197294 DOI: 10.1038/Nri2506  0.532
2009 Gabrilovich D. Mechanism of Myeloid-Derived Suppressor Cell Differentiation in Cancer. Blood. 114: SCI-31-SCI-31. DOI: 10.1182/Blood.V114.22.Sci-31.Sci-31  0.559
2009 Wei S, Chen X, Rocha K, Qi D, Tao J, Gjertsen N, Zhou J, Liu J, Gabrilovich D, Epling-Burnette PK, Djeu JY, List AF. Myeloid-Derived Suppressor Cells (MDSC) Are Effectors of Bone Marrow Suppression in Lower Risk Myelodysplastic Syndromes (MDS). Blood. 114: 597-597. DOI: 10.1182/Blood.V114.22.597.597  0.352
2009 Ahmed I, Gabrilovich D, Cheong D, Gonzalez R, Heysek R, Johnson D, Sondak V, Letson G, Antonia S, Finkelstein S. Novel Image Guided Visualization of Experimental Cellular-based Vaccines, In Vivo, during Combined Radiation/Immunotherapy Protocols International Journal of Radiation Oncology*Biology*Physics. 75: S564. DOI: 10.1016/J.Ijrobp.2009.07.1289  0.305
2009 Gabrilovich DI. A role for STAT3 in dendritic cell regulation by tumor-derived factors Dendritic Cells in Cancer. 143-155. DOI: 10.1007/978-0-387-88611-4_10  0.445
2008 Nefedova Y, Gabrilovich D. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 11: 210-8. PMID 18951834 DOI: 10.1016/J.Drup.2008.09.002  0.354
2008 Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. Journal of Immunology (Baltimore, Md. : 1950). 181: 5791-802. PMID 18832739 DOI: 10.4049/Jimmunol.181.8.5791  0.727
2008 Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. The Journal of Experimental Medicine. 205: 2235-49. PMID 18809714 DOI: 10.1084/Jem.20080132  0.757
2008 Daud AI, Mirza N, Lenox B, Andrews S, Urbas P, Gao GX, Lee JH, Sondak VK, Riker AI, Deconti RC, Gabrilovich D. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3235-41. PMID 18591558 DOI: 10.1200/Jco.2007.13.9048  0.343
2008 Ramakrishnan R, Antonia S, Gabrilovich DI. Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunology, Immunotherapy : Cii. 57: 1523-9. PMID 18488219 DOI: 10.1007/S00262-008-0531-4  0.452
2008 Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Research. 68: 2561-3. PMID 18413722 DOI: 10.1158/0008-5472.Can-07-6229  0.52
2008 Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 111: 2220-9. PMID 18039953 DOI: 10.1182/Blood-2007-07-102632  0.405
2008 Cheng P, Gabrilovich D. Notch signaling in differentiation and function of dendritic cells. Immunologic Research. 41: 1-14. PMID 18008056 DOI: 10.1007/s12026-007-8011-z  0.354
2008 Hazlehurst L, Dalton WS, Yarde D, Nefedova Y, Gabrilovich D. Influence of Targeted Therapy in Redefining High-Risk Myeloma. Blood. 112: sci-7-sci-7. DOI: 10.1182/Blood.V112.11.Sci-7.Sci-7  0.38
2008 Gabrilovich DI, Hurwitz AA. Tumor induced immune suppression: Mechanisms and therapeutic reversal Tumor Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 1-301. DOI: 10.1007/978-0-387-69118-3  0.346
2007 Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Research. 67: 11021-8. PMID 18006848 DOI: 10.1158/0008-5472.Can-07-2593  0.574
2007 Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Advances in Experimental Medicine and Biology. 601: 213-23. PMID 17713008 DOI: 10.1007/978-0-387-72005-0_22  0.548
2007 Fricke I, Mirza N, Dupont J, Lockhart C, Jackson A, Lee JH, Sosman JA, Gabrilovich DI. Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4840-8. PMID 17699863 DOI: 10.1158/1078-0432.Ccr-07-0409  0.518
2007 Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nature Medicine. 13: 828-35. PMID 17603493 DOI: 10.1038/Nm1609  0.437
2007 Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. The Journal of Experimental Medicine. 204: 1463-74. PMID 17548519 DOI: 10.1084/Jem.20062602  0.471
2007 Herber DL, Nagaraj S, Djeu JY, Gabrilovich DI. Mechanism and therapeutic reversal of immune suppression in cancer. Cancer Research. 67: 5067-9. PMID 17545581 DOI: 10.1158/0008-5472.Can-07-0897  0.459
2007 Nagaraj S, Pisarev V, Kinarsky L, Sherman S, Muro-Cacho C, Altieri DC, Gabrilovich DI. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 169-79. PMID 17471164 DOI: 10.1097/01.Cji.0000211329.83890.Ba  0.562
2007 Mirza N, Gabrilovich D. Comment on "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells". Journal of Immunology. 178: 4705-4706. PMID 17404244 DOI: 10.4049/Jimmunol.178.8.4705-A  0.36
2007 Nefedova Y, Gabrilovich DI. Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Current Cancer Drug Targets. 7: 71-7. PMID 17305479 DOI: 10.2174/156800907780006887  0.54
2007 Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Research. 67: 425; author reply 42. PMID 17210725 DOI: 10.1158/0008-5472.Can-06-3037  0.408
2007 Gabrilovich DI. Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited. The Lancet. Oncology. 8: 2-3. PMID 17196504 DOI: 10.1016/S1470-2045(06)70985-8  0.337
2007 Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annual Review of Immunology. 25: 267-96. PMID 17134371 DOI: 10.1146/Annurev.Immunol.25.022106.141609  0.551
2007 Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood. 109: 507-15. PMID 16973960 DOI: 10.1182/Blood-2006-05-025601  0.66
2007 Chiappori A, Sereno M, Gabrilovich D, Mirza N, Dunn M, Janssen W, Smilee R, Menander K, Chada S, Antonia S. Phase II trial of patients (pts) with extensive stage small cell lung cancer (ES-SCLC) immunized with p53-transduced dendritic cells (p53-DC): Immune sensitization to chemotherapy (CT) Journal of Clinical Oncology. 25: 3012-3012. DOI: 10.1200/Jco.2007.25.18_Suppl.3012  0.34
2007 Sosman JA, Fricke I, Mirza N, Dupont J, Lockhart AC, Jackson A, LaFleur B, Gabrilovich D. VEGF-Trap (V-T) overcomes defects in dendritic cell (DC) differentiation without improvement in antigen-specific immune responses Journal of Clinical Oncology. 25: 21087-21087. DOI: 10.1200/Jco.2007.25.18_Suppl.21087  0.452
2007 Antonia S, Mirza N, Chiappori A, Fricke I, Bepler G, Simon G, Janssen W, Lee J, Menander K, Chada S, Gabrilovich DI. M17-02: Immunotherapy of extensive stage small cell lung cancer with dendritic cell based p53 vaccine Journal of Thoracic Oncology. 2: S198-S199. DOI: 10.1097/01.Jto.0000282976.88618.Ff  0.38
2007 Gabrilovich D, Nagaraj S, Gupta K, Schneck J. Evaluation of antigen binding by CD8+ T cells after in vivo treatment with myeloid derived suppressor cells Nature Protocols. DOI: 10.1038/Nprot.2007.240  0.418
2007 Nagaraj S, Gabrilovich D. Evaluation of nitrotyrosine expression on the surface of CD8+ T cells Nature Protocols. DOI: 10.1038/Nprot.2007.239  0.332
2006 Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Reviews. 25: 323-31. PMID 16983515 DOI: 10.1007/S10555-006-9002-6  0.571
2006 Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, Lush RM, Antonia S, Gabrilovich DI. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Research. 66: 9299-307. PMID 16982775 DOI: 10.1158/0008-5472.Can-06-1690  0.485
2006 Fricke I, Gabrilovich DI. Dendritic cells and tumor microenvironment: a dangerous liaison. Immunological Investigations. 35: 459-83. PMID 16916762 DOI: 10.1080/08820130600803429  0.548
2006 Antonia SJ, Mirza N, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH, Menander K, Chada S, Gabrilovich DI. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 878-87. PMID 16467102 DOI: 10.1158/1078-0432.Ccr-05-2013  0.39
2006 Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunology, Immunotherapy : Cii. 55: 237-45. PMID 16047143 DOI: 10.1007/S00262-005-0048-Z  0.594
2006 Nefedova Y, Verali K, Sullivan DM, Dalton WS, Gabrilovich DI. A New Target in Multiple Myeloma: Inhibition of Notch Pathway Induces Apoptosis and Enhances Drug Sensitivity of Myeloma Cells In Vitro and In Vivo. Blood. 108: 841-841. DOI: 10.1182/Blood.V108.11.841.841  0.48
2005 Gabrilovich DI, Mirza N, Chiappori A, Dunn M, Willis M, Janssen W, Smilee R, Menander K, Chada S, Antonia S. Initial results of a phase II trial of patients with extensive stage small cell lung cancer (SCLC) immunized with dendritic cells (DC) transduced with wild-type p53. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2543. PMID 27945832 DOI: 10.1200/Jco.2005.23.16_Suppl.2543  0.469
2005 Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Research. 65: 9525-35. PMID 16230418 DOI: 10.1158/0008-5472.Can-05-0529  0.551
2005 Kusmartsev S, Nagaraj S, Gabrilovich DI. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 4583-92. PMID 16177103 DOI: 10.4049/Jimmunol.175.7.4583  0.545
2005 Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg AA, Sebti SM, Gabrilovich DI. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. Journal of Immunology (Baltimore, Md. : 1950). 175: 4338-46. PMID 16177074 DOI: 10.4049/Jimmunol.175.7.4338  0.444
2005 Maroof A, English NR, Bedford PA, Gabrilovich DI, Knight SC. Developing dendritic cells become 'lacy' cells packed with fat and glycogen. Immunology. 115: 473-83. PMID 16011516 DOI: 10.1111/J.1365-2567.2005.02181.X  0.418
2005 Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC. Rational design of shepherdin, a novel anticancer agent. Cancer Cell. 7: 457-68. PMID 15894266 DOI: 10.1016/J.Ccr.2005.03.035  0.459
2005 Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. Journal of Immunology (Baltimore, Md. : 1950). 174: 4880-91. PMID 15814715 DOI: 10.4049/Jimmunol.174.8.4880  0.565
2005 Gabrilovich DI. The neutrophils: New outlook for old cells The Neutrophils: New Outlook For Old Cells. 1-355. DOI: 10.1142/P340  0.355
2005 Gabrilovich D, Nagaraj S, Kusmartsev S. Tumor Associated CD8+ T-Cell Tolerance Induced by Bone Marrow Derived Immature Myeloid Cells Journal of Immunotherapy. 28: 648. DOI: 10.1097/01.Cji.0000191065.34501.E3  0.464
2005 Mirza NN, Antonia SJ, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Menander K, Chada S, Gabrilovich DI. Effective Combination of Cancer Vaccine With Chemotherapy in Patients With Extensive Stage Lung Cancer Journal of Immunotherapy. 28: 612-613. DOI: 10.1097/01.Cji.0000190947.95008.45  0.306
2004 Cheng F, Gabrilovich D, Sotomayor EM. Immune tolerance in breast cancer. Breast Disease. 20: 93-103. PMID 15687711 DOI: 10.3233/Bd-2004-20111  0.456
2004 Gabrilovich DI. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature Reviews Immunology. 4: 941-952. PMID 15573129 DOI: 10.1038/Nri1498  0.454
2004 Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology (Baltimore, Md. : 1950). 172: 989-99. PMID 14707072 DOI: 10.4049/Jimmunol.172.2.989  0.531
2004 Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine. 10: 48-54. PMID 14702634 DOI: 10.1038/Nm976  0.564
2004 Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. Journal of Immunology (Baltimore, Md. : 1950). 172: 464-74. PMID 14688356 DOI: 10.4049/Jimmunol.172.1.464  0.557
2004 Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 103: 3503-10. PMID 14670925 DOI: 10.1182/Blood-2003-07-2340  0.462
2004 Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Erratum: Corrigendum: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nature Medicine. 10: 209-209. DOI: 10.1038/Nm0204-209B  0.403
2003 Gabrilovich D, Pisarev V. Tumor escape from immune response: mechanisms and targets of activity. Current Drug Targets. 4: 525-36. PMID 14535653 DOI: 10.2174/1389450033490849  0.533
2003 Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Research. 63: 4441-9. PMID 12907617  0.458
2003 Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood. 102: 3980-8. PMID 12907456 DOI: 10.1182/Blood-2003-04-1034  0.436
2003 Kusmartsev S, Gabrilovich DI. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. Journal of Leukocyte Biology. 74: 186-96. PMID 12885935 DOI: 10.1189/Jlb.0103010  0.495
2003 Chada S, Mhashilkar A, Roth JA, Gabrilovich D. Development of vaccines against self-antigens: the p53 paradigm. Current Opinion in Drug Discovery & Development. 6: 169-73. PMID 12669451  0.354
2003 Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, Carbone DP. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood. 101: 4878-86. PMID 12586633 DOI: 10.1182/Blood-2002-07-1956  0.447
2002 Gabrilovich DI. Dendritic cell vaccines for cancer treatment. Current Opinion in Molecular Therapeutics. 4: 452-8. PMID 12435046  0.444
2002 Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors. Journal of Leukocyte Biology. 72: 285-96. PMID 12149419  0.364
2002 Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunology, Immunotherapy : Cii. 51: 293-8. PMID 12111117 DOI: 10.1007/S00262-002-0280-8  0.558
2002 Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A, et al. Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 25: 97-138. PMID 12074049 DOI: 10.1097/00002371-200203000-00001  0.405
2002 Nikitina EY, Chada S, Muro-Cacho C, Fang B, Zhang R, Roth JA, Gabrilovich DI. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Therapy. 9: 345-52. PMID 11938454 DOI: 10.1038/Sj.Gt.3301670  0.485
2002 Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. H1° histone and differentiation of dendritic cells. A molecular target for tumor-derived factors Journal of Leukocyte Biology. 72: 285-296. DOI: 10.1189/Jlb.72.2.285  0.509
2001 Gabrilovich D. Isolation of dendritic cells from mouse lymph nodes. Methods in Molecular Medicine. 64: 3-7. PMID 21374244 DOI: 10.1385/1-59259-150-7:3  0.312
2001 Nikitina E, Gabrilovich DI. Combination of γ-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer International Journal of Cancer. 94: 825-833. PMID 11745485 DOI: 10.1002/1097-0215(20011215)94:6<825::Aid-Ijc1545>3.0.Co;2-5  0.51
2001 Lisziewicz J, Gabrilovich DI, Varga G, Xu J, Greenberg PD, Arya SK, Bosch M, Behr JP, Lori F. Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells. Journal of Virology. 75: 7621-8. PMID 11462034 DOI: 10.1128/Jvi.75.16.7621-7628.2001  0.398
2001 Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells Journal of Immunology. 166: 5398-5406. PMID 11313376 DOI: 10.4049/Jimmunol.166.9.5398  0.556
2001 Young MRI, Petruzzelli GJ, Kolesiak K, Achille N, Lathers DMR, Gabrilovich DI. Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cells Human Immunology. 62: 332-341. PMID 11295465 DOI: 10.1016/S0198-8859(01)00222-1  0.416
2001 Nikitina EY, Clark JI, Van Beynen J, Chada S, Virmani AK, Carbone DP, Gabrilovich DI. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 127-35. PMID 11205900  0.346
2001 Almand B, Clark JI, Nikitina E, Van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer Journal of Immunology. 166: 678-689. PMID 11123353 DOI: 10.4049/Jimmunol.166.1.678  0.56
2001 Shurin MR, Gabrilovich DI. Regulation of dendritic cell system by tumor Cancer Research, Therapy and Control. 11: 65-78.  0.442
2000 Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Clinical significance of defective dendritic cell differentiation in cancer Clinical Cancer Research. 6: 1755-1766. PMID 10815894  0.42
1999 Young MR, Kolesiak K, Wright MA, Gabrilovich DI. Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clinical & Experimental Metastasis. 17: 881-8. PMID 11089887 DOI: 10.1023/A:1006708607666  0.368
1999 Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clinical Cancer Research. 5: 2963-2970. PMID 10537366  0.344
1998 Ishida T, Oyama T, Carbone DP, Gabrilovich DI. Defective function of langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors Journal of Immunology. 161: 4842-4851. PMID 9794417  0.397
1998 Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP. Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo Blood. 92: 4150-4166. DOI: 10.1182/Blood.V92.11.4150.423K45_4150_4166  0.449
1997 Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer Clinical Cancer Research. 3: 483-490. PMID 9815709  0.376
1997 Gabrilovich D, Kavanaugh D, Ishida T, Ovama I, Lee CJ, Nadaf S, Sepetavec T, Jensen R, Gazdar A, Ciernik I, Corak J, Berzofsky J, Carbone DP. Induction of p53ras specific cellular immunity in patients with common solid tumors Lung Cancer. 18: 90-91. DOI: 10.1016/S0169-5002(97)83913-X  0.446
1996 Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nature Medicine. 2: 1096-1103. PMID 8837607 DOI: 10.1038/Nm1096-1096  0.474
1996 Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Dendritic cells in antitumor immune responses II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors Cellular Immunology. 170: 111-119. PMID 8665591 DOI: 10.1006/cimm.1996.0140  0.424
1996 Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses I. Defective antigen presentation in tumor-bearing hosts Cellular Immunology. 170: 101-110. PMID 8665590 DOI: 10.1006/cimm.1996.0139  0.434
1996 Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Erratum: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (Nature Medicine 2, 1096-1103 (1996)) Nature Medicine. 2. DOI: 10.1038/Nm1196-1267  0.374
1995 Woods GM, Gabrilovich DI, Elsley W, English N, Knight SC. Dendritic cells, apoptosis and murine retrovirus. Advances in Experimental Medicine and Biology. 378: 493-6. PMID 8526126 DOI: 10.1007/978-1-4615-1971-3_111  0.421
1994 Gabrilovich DI, Patterson S, Harvey JJ, Woods GM, Elsley W, Knight SC. Murine Retrovirus Induces Defects in the Function of Dendritic Cells at Early Stages of Infection Cellular Immunology. 158: 167-181. PMID 8087863 DOI: 10.1006/Cimm.1994.1265  0.35
1993 Gabrilovich DI, Roberts MS, Harvey JJ, Botcherby M, Bedford PA, Knight SC. Effects of murine leukemia viruses on the function of dendritic cells European Journal of Immunology. 23: 2932-2938. PMID 8223870 DOI: 10.1002/Eji.1830231131  0.412
Show low-probability matches.